PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastric cancer |
| Symptom | C0242379|lung cancer |
| Sentences | 6 |
| PubMedID- 22996774 | Results: thirteen cases of lung cancer, eight with gastric cancer, and one with esophageal cancer, were retrospectively evaluated. |
| PubMedID- 26468480 | In this study, 60 patients with gastric and lung cancers (33 cases with gastric cancer and 27 cases with lung cancer) were enrolled in 2 groups of 30 patients. |
| PubMedID- 22581909 | Only surgical resection can identify the second primary lung cancer out of the metastasis after gastric cancer surgery. |
| PubMedID- 25908993 | Since it is known that as the risk for lung cancer increases, that of gastric cancer also dose, the above-mentioned result provide an important evidence suggesting that the incidence of gastric cancer of this patient was related to his asbestos fiber exposure. |
| PubMedID- 25947890 | Kurishima and colleagues had reported that the incidence rate of synchronous gastric cancer in patients with lung cancer was 3.2% . |
| PubMedID- 26496252 | Bevacizumab is a recombinant, humanized murine monoclonal antibody against vascular endothelial growth factor a (vegf-a).9 bevacizumab has been shown effective when used alone or in combination with other chemotherapies in treating several malignancies, such as metastatic renal cell cancer,10 metastatic colorectal cancer,11 metastatic breast cancer,12 and metastatic nonsquamous nonsmall-cell lung cancer.13 in patients with advanced gastric cancer, several phase ii studies suggest that the addition of bevacizumab improves the efficacy of chemotherapy, such as oxaliplatin, docetaxel, cisplatin, and fluorouracil.14,15 although the initial results of the phase iii study avagast did not show beneficial effects of bevacizumab for patient survival as the first-line treatment for advanced gastric cancer,16 further analysis of the data suggest that certain subgroups may have benefited from the addition of bevacizumab to chemotherapy. |
Page: 1